Zhang et al. [192], in a recent study, found that this miR was down-regulated in patients with SLE and could decrease IL17 levels and suppress renal fibrosis via down-regulating TGF-β1 in LN mice. This evidence concerns the gene TGFB1 and lobular neoplasia.